Acuren Corporation PDMR/PCA Notifications
02 August 2024 - 10:50PM
RNS Regulatory News
RNS Number : 0382Z
Acuren Corporation
02 August 2024
For immediate release
Acuren
Corporation
(formerly known as Admiral
Acquisition Limited)
2 August 2024
PDMR/PCA
NOTIFICATIONS
Acuren Corporation (formerly known
as Admiral Acquisition Limited) (LSE: ADMR / ADMW)
announces that it has received the following
notifications on 31 July 2024 from certain persons discharging
managerial responsibilities and persons closely associated with
them.
The notifications below are made in
accordance with the Market Abuse Regulation.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Mariposa Acquisition IX,
LLC
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
PCA of Sir Martin E. Franklin,
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Exercise of warrants to subscribe
for ordinary shares
|
|
c)
|
Price(s) and volume(s)
|
9,950,000 warrants exercised at
$10.00 per whole ordinary share for 2,487,500 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Mariposa Acquisition IX,
LLC
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
PCA of Sir Martin E. Franklin,
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Acquisition of ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
7,440,000 ordinary shares at $10.00
per ordinary share
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Rory Cullinan
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Exercise of warrants to subscribe
for ordinary shares.
|
|
c)
|
Price(s) and volume(s)
|
10,000 warrants exercised at $10.00
per whole ordinary share for 2,500 ordinary shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Rory Cullinan
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units
vesting 30 July 2025
|
|
c)
|
Price(s) and volume(s)
|
N/A, 10,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Talman Pizzey
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Acquisition of ordinary
shares
|
|
c)
|
Price(s) and volume(s)
|
400,000 ordinary shares at $10.00
per ordinary share
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Talman Pizzey
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units with
(i) half of such units vesting one third on each anniversary of the
date of grant, being 30 July 2024 and (ii) half of such units
vesting on the later of the first anniversary of the date of grant
or the date on which Acuren's share price reaches $20 once listed
on the NYSE
|
|
c)
|
Price(s) and volume(s)
|
N/A, 220,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Michael Grigsby
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units with
(i) half of such units vesting one third on each anniversary of the
date of grant, being 30 July 2024 and (ii) half of such units
vesting on the later of the first anniversary of the date of grant
or the date on which Acuren's share price reaches $20 once listed
on the NYSE
|
|
c)
|
Price(s) and volume(s)
|
N/A, 170,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
James E. Lillie
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units
vesting 30 July 2025
|
|
c)
|
Price(s) and volume(s)
|
N/A, 10,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Peter Hochfelder
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units
vesting 30 July 2025
|
|
c)
|
Price(s) and volume(s)
|
N/A, 10,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Elizabeth Meloy Hepding
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units
vesting 30 July 2025
|
|
c)
|
Price(s) and volume(s)
|
N/A, 10,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
Antoinette Bush
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
ACUREN CORPORATION
|
|
b)
|
LEI
|
213800ZDFRNC8QXEZ481
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument / Identification code
|
Ordinary Shares
ISIN: VGG0093S1092
|
|
b)
|
Nature of the transaction
|
Award of restricted stock units
vesting 30 July 2025
|
|
c)
|
Price(s) and volume(s)
|
N/A, 10,000 ordinary
shares
|
|
d)
|
Aggregated information
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
30 July 2024
|
|
f)
|
Place of the transaction
|
Outside of a trading
venue
|
--Ends--
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHPTMTTMTIMBLI
Acuren (LSE:ADMR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Acuren (LSE:ADMR)
Historical Stock Chart
From Nov 2023 to Nov 2024
